Key points are not available for this paper at this time.
The 23-valent pneumococcal polysaccharide (Ps) vaccine offer protection against vaccine serotypes, but its cross-protection against vaccine-related serotypes is variable. We have demonstrated that the functional antibodies to serotype 15B are specific to the O-acetylated 15B-Ps and that they have low cross-reactivity with serotype 15C. Demonstration of functionally cross-reactive antibodies to vaccine-related serotypes is important for surveillance and vaccine development.
Building similarity graph...
Analyzing shared references across papers
Loading...
Gowrisankar Rajam
Merck & Co., Inc., Rahway, NJ, USA (United States)
George M. Carlone
Centers for Disease Control and Prevention
Sandra Romero‐Steiner
Oklahoma State Department of Health
Clinical and Vaccine Immunology
Centers for Disease Control and Prevention
Building similarity graph...
Analyzing shared references across papers
Loading...
Rajam et al. (Wed,) studied this question.
synapsesocial.com/papers/6a0378fc8cb95a7d958a32c5 — DOI: https://doi.org/10.1128/cvi.00184-07